Spotlight on PSMA as a new theranostic biomarker for bladder cancer

Spotlight on PSMA as a new theranostic biomarker for bladder cancer

Abstract Bladder cancer (BCa) patients are diagnosed by cytology and cystoscopy. However, these diagnostic tests bear some limitations. We sought for reliable biomarkers to better determine BCa extension. Prostate-specific membrane antigen (PSMA) appears to fulfill this requirement in prostate cance...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, Monica Celli, Ugo De Giorgi, Roberta Gunelli, Maurizio Puccetti, Giovanni Paganelli, Sara Bravaccini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/9e48e4bb4424421c8efc0070bd91a8d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares